Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mitochondria Antibody (113-1), Alexa Fluor™ 594, Novus Biologicals™
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP234517AF594
Description
Mitochondria Monoclonal specifically detects Mitochondria in Human, Mouse (Negative), Rat (Negative) samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.Specifications
Mitochondria | |
Monoclonal | |
Alexa Fluor 594 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
Semi-purified mitochondrial preparation | |
0.1 mL | |
Primary | |
Human, Mouse (Negative), Rat (Negative) | |
IgG1 κ |
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
113-1 | |
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
Mouse | |
Protein A or G purified | |
RUO | |
This monoclonal antibody recognizes a 60kDa antigen associated with the mitochondria in human cells. It can be used to stain mitochondria in cell or tissue preparations and can be used as a mitochondrial marker in subcellular fractions. It produces a spaghetti-like pattern in normal and malignant cells. This antibody is an excellent marker for human cells in xenographic model research. It reacts specifically with human cells, including neurons and embryonic stem cells. Immunostaining pattern with anti-mitochondrial monoclonal antibody has been reported as a useful discriminatory adjunct in the complex differential diagnosis of granular renal cell tumors. Reportedly, this monoclonal antibody facilitates the classification of salivary tumors. | |
Store at 4°C in the dark. |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction